97 related articles for article (PubMed ID: 2190031)
1. [Removal of small molecular proteins by push/pull HDF and alleviation of shoulder joint pain].
Usuda M; Maeda K; Yamada K
Nihon Jinzo Gakkai Shi; 1990 Jan; 32(1):25-31. PubMed ID: 2190031
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of push/pull hemodiafiltration using large-pore membrane for shoulder joint pain in long-term dialysis patients.
Maeda K; Kobayakawa H; Fujita Y; Takai I; Morita H; Emoto Y; Miyazaki T; Shinzato T
Artif Organs; 1990 Oct; 14(5):321-7. PubMed ID: 2241598
[TBL] [Abstract][Full Text] [Related]
3. Hemofiltration or hemodiafiltration with on-line production of substitution fluid: clinical observation of safety and effectiveness.
Li X; Li M; Liu T; Li L; Duan L; Li Y; Yang G; Guo L
Chin Med J (Engl); 1997 Jul; 110(7):520-5. PubMed ID: 9594209
[TBL] [Abstract][Full Text] [Related]
4. Comparison of various treatment modes in terms of beta 2-microglobulin removal: hemodialysis, hemofiltration, and push/pull HDF.
Shinzato T; Kobayakawa H; Maeda K
Artif Organs; 1989 Feb; 13(1):66-70. PubMed ID: 2653287
[TBL] [Abstract][Full Text] [Related]
5. Matching efficacy of online hemodiafiltration in simple hemodialysis mode.
Krieter DH; Hunn E; Morgenroth A; Lemke HD; Wanner C
Artif Organs; 2008 Dec; 32(12):903-9. PubMed ID: 19133017
[TBL] [Abstract][Full Text] [Related]
6. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients.
Zehnder C; Gutzwiller JP; Renggli K
Clin Nephrol; 1999 Sep; 52(3):152-9. PubMed ID: 10499310
[TBL] [Abstract][Full Text] [Related]
7. Push/pull hemodiafiltration: technical aspects and clinical effectiveness.
Miwa M; Shinzato T
Artif Organs; 1999 Dec; 23(12):1123-6. PubMed ID: 10619932
[TBL] [Abstract][Full Text] [Related]
8. A circulating beta 2-microglobulin intermediate in hemodialysis patients.
Uji Y; Motomiya Y; Ando Y
Nephron Clin Pract; 2009; 111(3):c173-81. PubMed ID: 19194107
[TBL] [Abstract][Full Text] [Related]
9. [Middle molecules removal. Beyond beta2-microglobulin].
Maduell F; Sánchez-Canel JJ; Blasco JA; Navarro V; Ríus A; Torregrosa E; Pin MT; Cruz C; Ferrero JA
Nefrologia; 2006; 26(4):469-75. PubMed ID: 17058859
[TBL] [Abstract][Full Text] [Related]
10. Beta2-microglobulin amyloidosis in hemodialysis and peritoneal dialysis patients.
Dervisoglu E; Anik Y; Erdogan S; Akansel G; Yilmaz A
Ther Apher Dial; 2008 Aug; 12(4):306-10. PubMed ID: 18789118
[TBL] [Abstract][Full Text] [Related]
11. [What does circulating beta 2 microglobulin signify in uremic patients on maintenance dialysis?].
Assounga A; Canaud B; Flavier JL; Slingeneyer A; Robinet-Lévy M; Aznar R; Mion C
Nephrologie; 1987; 8(6):301-6. PubMed ID: 3330579
[TBL] [Abstract][Full Text] [Related]
12. [Cardiovascular risk markers in hemodialysis].
Urso S; Milone F; Garozzo M; Cannavò ME; Biondi A; Battaglia G
G Ital Nefrol; 2004; 21 Suppl 30():S212-6. PubMed ID: 15750988
[TBL] [Abstract][Full Text] [Related]
13. Impact of convective flow on phosphorus removal in maintenance hemodialysis patients.
Lornoy W; De Meester J; Becaus I; Billiouw JM; Van Malderen PA; Van Pottelberge M
J Ren Nutr; 2006 Jan; 16(1):47-53. PubMed ID: 16414441
[TBL] [Abstract][Full Text] [Related]
14. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial.
Santoro A; Mancini E; Bolzani R; Boggi R; Cagnoli L; Francioso A; Fusaroli M; Piazza V; Rapanà R; Strippoli GF
Am J Kidney Dis; 2008 Sep; 52(3):507-18. PubMed ID: 18617304
[TBL] [Abstract][Full Text] [Related]
15. Pilot study to assess increased dialysis efficiency in patients with limited blood flow rates due to vascular access problems.
Mandolfo S; Borlandelli S; Imbasciati E; Badalamenti S; Graziani G; Sereni L; Varesani M; Wratten ML; Corsi A; Elli A
Hemodial Int; 2008 Jan; 12(1):55-61. PubMed ID: 18271842
[TBL] [Abstract][Full Text] [Related]
16. Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration.
Fry AC; Singh DK; Chandna SM; Farrington K
Blood Purif; 2007; 25(3):295-302. PubMed ID: 17622712
[TBL] [Abstract][Full Text] [Related]
17. Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial.
Meert N; Eloot S; Waterloos MA; Van Landschoot M; Dhondt A; Glorieux G; Ledebo I; Vanholder R
Nephrol Dial Transplant; 2009 Feb; 24(2):562-70. PubMed ID: 18809977
[TBL] [Abstract][Full Text] [Related]
18. Different elimination patterns of beta-trace protein, beta2-microglobulin and cystatin C in haemodialysis, haemodiafiltration and haemofiltration.
Lindström V; Grubb A; Alquist Hegbrant M; Christensson A
Scand J Clin Lab Invest; 2008; 68(8):685-91. PubMed ID: 18609120
[TBL] [Abstract][Full Text] [Related]
19. The impact of dialysis modality on skin hyperpigmentation in haemodialysis patients.
Moon SJ; Kim DK; Chang JH; Kim CH; Kim HW; Park SY; Han SH; Lee JE; Yoo TH; Han DS; Kang SW
Nephrol Dial Transplant; 2009 Sep; 24(9):2803-9. PubMed ID: 19342419
[TBL] [Abstract][Full Text] [Related]
20. Effect of high fiber density ratio polysulfone dialyzer on protein removal.
Tomo T; Matsuyama M; Nakata T; Kadota J; Toma S; Koga N; Fukui H; Arizono K; Takamiya T; Matsuyama K; Ueyama S; Shiohira Y; Uezu Y; Higa A
Blood Purif; 2008; 26(4):347-53. PubMed ID: 18487878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
